نتایج جستجو برای: sporadic prostate cancer

تعداد نتایج: 951267  

ژورنال: پژوهش در پزشکی 2009
خاتمی*1،, فاطمه, زالی1, محمد رضا, سلطانی1،, معصومه, غیاثی1،, سمیه, محبی1،, سید رضا, منتظر حقیقی1،, مهدی,

Abstract Background: Sporadic colorectal cancer is the fourth most common cancer in Iran. The DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) is involved in the cellular defense against alkylating agents. Genetic alterations in the MGMT gene may impair the protein’s ability to remove alkyl groups from the O6-position of guanine, thereby raising the mutation rate and increasi...

Journal: :acta medica iranica 0
mostafa hosseini department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. seyed meisam ebrahimi faculty of nursing and midwifery, tehran university of medical sciences, tehran, iran. seyedahmad seyedalinaghi iranian research center for hiv/aids (ircha), tehran university of medical sciences, tehran, iran. mahmood mahmoodi iranian research center for hiv/aids (ircha), tehran university of medical sciences, tehran, iran.

we assessed the lower urinary tract symptoms (luts) in prostatic cancer patients and investigated the sensitivity and specificity of international prostate symptom score (ipss) in the screening of these patients. a total number of 132 prostatic cancer patients as the case group who were confirmed by the pathologists and 101 noncancerous men as the control group, aged 50 or older, responded to a...

Journal: :Japanese journal of clinical oncology 2000
A Ozet A A Yavuz S Kömürcü B Oztürk M Safali F Arpaci Z Caliskaner

Male breast cancer, consisting only 1% of all breast cancers, is occasionally associated with other primary malignancies, especially in patients with familial breast cancer history. Sporadic male breast cancers with another primary tumor are extremely rare. We report a 67-year-old male with asynchronous bilateral breast cancer and prostate cancer without familial breast cancer history.

Journal: :Asian journal of andrology 2012
Elena Castro Rosalind Eeles

One of the strongest risk factors for prostate cancer is a family history of the disease. Germline mutations in the breast cancer predisposition gene 2 (BRCA2) are the genetic events known to date that confer the highest risk of prostate cancer (8.6-fold in men ≤65 years). Although the role of BRCA2 and BRCA1 in prostate tumorigenesis remains unrevealed, deleterious mutations in both genes have...

Journal: :gastroenterology and hepatology from bed to bench 0
seyed reza mohebbi fatemeh khatami somaye ghiasi faramarz derakhshan hamid atarian mohammad reza zali

aim : to investigate association between mthfr gene polymorphism with colorectal cancer. background : the enzyme 5,10-methylene-tetrahydrofolate reductase (mthfr) is linked to dna methylation, synthesis and repair. one of the most important polymorphisms that has been identified in the mthfr gene is c677t. the single nucleotide polymorphism c677t has been found to be associated with decreased e...

Journal: :Cancer research 2002
Bao-li Chang Siqun L Zheng Gregory A Hawkins Sarah D Isaacs Kathy E Wiley Aubrey Turner John D Carpten Eugene R Bleecker Patrick C Walsh Jeffrey M Trent Deborah A Meyers William B Isaacs Jianfeng Xu

3beta-hydroxysteroid dehydrogenases (HSD3Bs), encoded by the HSD3B gene family at 1p13, have long been hypothesized to have a major role in prostate cancer susceptibility. The recent reports of a prostate cancer linkage at 1p13 provided additional evidence that HSD3B genes may be prostate cancer susceptibility genes. To evaluate the possible role of HSD3B genes in prostate cancer, we screened a...

Journal: :nephro-urology monthly 0
evangelos mazaris urology department, lister hospital, stevenage, united kingdom alexios tsiotras urology department, lister hospital, stevenage, united kingdom; urology department, lister hospital, stevenage, united kingdom. tel: +44-7580348549, fax: +44-1438515601

results like other cancers, prostate cancer is caused by an accumulation of genetic alterations in a cell that drives it to malignant growth. specific genes and gene alterations have been suggested to play a role in its development and progression. aneuploidy, loss of heterozygosity, gene mutations, hypermethylation and inactivation of specific tumour suppressor genes such as gstpi, apc, mdr1, ...

2007
Albert M. Levin Kimberly A. Zuhlke Anna M. Ray Kathleen A. Cooney Julie A. Douglas

BACKGROUND. Expression of the a-methylacyl-CoA racemase (AMACR) gene has been established as a sensitive and specific biomarker for the diagnosis of prostate cancer. An initial study has also suggested that the risk of familial (but not sporadic) prostate cancer may be associated with germline variation in the AMACR gene. METHODS. In a study of brothers discordant for the diagnosis of prostate ...

Journal: :nursing practice today 0
nasser ibrahim abu el noor college of nursing, islamic university of gaza, gaza, gaza strip, palestine. mysoon khalil abu el noor college of nursing, islamic university of gaza, gaza, gaza strip, palestine.

background & aim : prostate cancer is one of the most common cancers in males and the second leading cause of cancer-related deaths in palestine. although, many studies were conducted in de- veloped countries to evaluate quality of life (qol) in survivors of prostate cancer, the researchers could not find any study that was conducted in a developing country including palestine. therefore, the p...

Journal: :acta medica iranica 0
mostafa hosseini department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. seyed ahmad seyedalinaghi iranian research center for hiv/aids (ircha), tehran university of medical sciences, tehran, iran. mahmoud mahmoudi department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. willi mcfarland department of epidemiology and biostatistics, university of california, san francisco, usa.

prostate cancer is a major cause of morbidity and mortality in iran, yet there are few studies examining risk factors specific to the iranian context. we conducted a case-control study to explore risk factors for prostate cancer in mazandaran, iran from 2005 to 2008. the cases were 137 men with clinicopathologically confirmed prostate cancer. controls were 137 neighborhood and age match men wit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید